Active	Status	Sponsor type	Region	Phase	Filter
14 Active 1 Inactive 15 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

6 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Fry, James A
EBS-101-TD-391, NCT06021522: A Study to Evaluate Long-term Safety of Ecopipam Tablets in Children, Adolescents and Adults With Tourette's Disorder	Recruiting	3	150	Europe, Canada, US, RoW	Ecopipam, Ecopipam Hydrochloride	Emalex Biosciences Inc.	Tourette Syndrome	11/24	03/27
D1AMOND, NCT05615220: Ecopipam Tablets to Study Tourette's Disorder in Children, Adolescents and Adults	Active, not recruiting	3	196	Europe, Canada, US, RoW	Ecopipam Hydrochloride	Emalex Biosciences Inc.	Tourette Disorder	12/24	12/24
Isaacs, David A
EBS-101-TD-391, NCT06021522: A Study to Evaluate Long-term Safety of Ecopipam Tablets in Children, Adolescents and Adults With Tourette's Disorder	Recruiting	3	150	Europe, Canada, US, RoW	Ecopipam, Ecopipam Hydrochloride	Emalex Biosciences Inc.	Tourette Syndrome	11/24	03/27
D1AMOND, NCT05615220: Ecopipam Tablets to Study Tourette's Disorder in Children, Adolescents and Adults	Active, not recruiting	3	196	Europe, Canada, US, RoW	Ecopipam Hydrochloride	Emalex Biosciences Inc.	Tourette Disorder	12/24	12/24
NCT03417583: Assessing Efficacy of Neuropsychiatric Assessment and Treatment Protocols in Huntington's Disease Patients	Completed	N/A	100	US	Protocol Intervention Group	Vanderbilt University Medical Center, Teva Pharmaceuticals USA	Huntington Disease	01/23	10/23
Eckland, Michelle
D1AMOND, NCT05615220: Ecopipam Tablets to Study Tourette's Disorder in Children, Adolescents and Adults	Active, not recruiting	3	196	Europe, Canada, US, RoW	Ecopipam Hydrochloride	Emalex Biosciences Inc.	Tourette Disorder	12/24	12/24